We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
STOR
STORE Capital Corporation
STOR
+$172M
3
FHN icon
First Horizon
FHN
+$107M
4
COUP
Coupa Software Incorporated
COUP
+$96.9M
5
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
+$64.6M

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
AVLR
Avalara, Inc.
AVLR
+$373M
4
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M
5
ROG icon
Rogers Corp
ROG
+$219M

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MITA icon
376
DELISTED
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
$2.38M 0.04%
236,311
-2,312
-1% -$23K
2021 Q3
5 quarters
DTI icon
377
Drilling Tools International
DTI
$71.3M
$2.37M 0.04%
231,686
-2,267
-1% -$22.9K
2022 Q1
3 quarters
FRON
378
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
$2.37M 0.04%
235,543
-2,305
-1% -$23.1K
2021 Q2
6 quarters
DLCA
379
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
$2.37M 0.04%
235,307
-2,312
-1% -$23.2K
2021 Q1
7 quarters
PARA icon
380
Banzai International
PARA
$2.57M
$2.37M 0.04%
23
-1
-4% -$100K
2021 Q1
7 quarters
PMGM icon
381
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$2.37M 0.04%
233,953
– –
2021 Q3
5 quarters
AEAC
382
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
$2.37M 0.04%
234,377
-2,303
-1% -$23.1K
2021 Q1
7 quarters
PFTA icon
383
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
$2.37M 0.04%
236,311
-2,312
-1% -$23K
2021 Q3
5 quarters
ORIA
384
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$2.37M 0.04%
235,390
-2,303
-1% -$22.9K
2021 Q3
5 quarters
PNST icon
385
DELISTED
Pinstripes Holdings, Inc.
PNST
$2.37M 0.04%
231,686
-2,267
-1% -$22.9K
2022 Q1
3 quarters
TGVC
386
DELISTED
TG Venture Acquisition Corp. Class A Common Stock
TGVC
$2.36M 0.04%
231,686
-2,267
-1% -$22.8K
2021 Q4
4 quarters
KVSC
387
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$2.36M 0.04%
237,220
-2,321
-1% -$23K
2021 Q1
7 quarters
GXII
388
DELISTED
GX Acquisition Corp. II Class A Common Stock
GXII
$2.35M 0.04%
235,206
-2,302
-1% -$22.8K
2021 Q2
6 quarters
PEN icon
389
Penumbra
PEN
$12.6B
$2.35M 0.04%
10,576
+1,669
+19% +$326K
2022 Q1
3 quarters
CSLM icon
390
DELISTED
CSLM Acquisition Corp. Class A Ordinary Share
CSLM
$2.35M 0.04%
231,686
-2,267
-1% -$22.7K
2022 Q1
3 quarters
IGTA icon
391
DELISTED
Inception Growth Acquisition Limited Common Stock
IGTA
$2.35M 0.04%
231,686
-2,267
-1% -$22.7K
2022 Q1
3 quarters
KNSA icon
392
Kiniksa Pharmaceuticals
KNSA
$6.13B
$2.35M 0.04%
156,962
+16,000
+11% +$233K
2022 Q3
1 quarter
OSI icon
393
DELISTED
Osiris Acquisition Corp.
OSI
$2.35M 0.04%
235,390
-2,303
-1% -$22.9K
2021 Q3
5 quarters
AOGO icon
394
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
$2.35M 0.04%
231,686
-2,267
-1% -$22.7K
2022 Q2
2 quarters
ASBP icon
395
Aspire-Lakewood Holdings, Inc. Common Stock
ASBP
$11.5M
$2.35M 0.04%
190
-1
-0.5% -$12.2K
2022 Q2
2 quarters
AXTA icon
396
Axalta
AXTA
$7.18B
$2.35M 0.04%
92,070
– –
2018 Q4
16 quarters
EPHY
397
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$2.34M 0.04%
234,376
-2,303
-1% -$23K
2021 Q1
7 quarters
INSP icon
398
Inspire Medical Systems
INSP
$1.99B
$2.34M 0.04%
9,300
-5,000
-35% -$1.07M
2022 Q3
1 quarter
VBOC
399
DELISTED
Viscogliosi Brothers Acquisition Corp Common Stock
VBOC
$2.34M 0.04%
231,686
-2,267
-1% -$22.7K
2022 Q1
3 quarters
APMI icon
400
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
$2.34M 0.04%
236,311
-2,312
-1% -$22.7K
2021 Q4
4 quarters
14 15
16
17 18

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.